An observational study in Cancer Patients With Delirium, sponsored by Memorial Sloan Kettering Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-08-22.
Sponsored by Memorial Sloan Kettering Cancer Center · Observational
The purpose of this study is to improve our understanding of the experience of music therapy by cancer patients with delirium, and the experience of music therapists working with these patients. The researchers are focusing on patients with delirium because of the challenging symptoms of this condition.
At MSK, music therapy is routinely used in patients with cancer. Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.
1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.
This study's enrollment of 17 is below the median of 200 across 418 observational studies indexed under Delirium.
Browse Delirium studies →Memorial Sloan Kettering Cancer Center is the lead sponsor of 1,930 studies on the registry; 325 are open to participants now.
Of its 129 completed or terminated interventional studies of FDA-regulated products, 66 (51%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patient subjects who are referred for music therapy will be identified to the researcher by a board-certified music therapist on staff at MSKCC (excluding the Principal Investigator).
This study will also include their caregivers, music therapists, primary nurse, and bedside companions who have participated in or observed the participants' response to music therapy.
The music therapist participants are:
The caregivers are:
The staff caregivers are:
Exclusion Criteria:
Caregivers will be excluded from the study if they do not speak English. Music therapists, nurses, or bedside companions will be excluded if they are not assigned to eligible patients.
Participate in 30-60 minute interviews after each music therapy session.
Behavioral: Music therapy · Behavioral: Interviews
Participate in 30-60 minute interviews after each music therapy session (ideally within 3 days).
Behavioral: Music therapy · Behavioral: Interviews
Participate in 10-15 minute interviews after initial music therapy session.
Behavioral: Music therapy · Behavioral: Interviews
Music therapist will notify the researcher if he/she has provided music therapy for a patient who is identified as having delirium. Music therapists will also be interviewed about the clinical process after initial and follow up music sessions.
Behavioral: Interviews
Music therapy sessions may last 20-60 minutes, with length and frequency to be determined mutually (generally 1-3 times per week). Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.
Each interview will be conducted in person in a private setting (with the exception of caregivers, who have the option to conduct interviews over the phone if it is not feasible to take place in the hospital). Each interview will follow a semi-structured interview guide and will ask for consent to audio record the interviews .
thematic analysis of data with music therapists
by interviews
Time frame: 1 year
thematic analysis of data with caregivers, nurses, and patients
by interviews
Time frame: 1 year
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Memorial Sloan Kettering Cancer Center